|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA07010722
|
2-Methylallyl butyrate
|
2-methylprop-2-en-1-yl butanoate
|
SFE 8:1
|
C8H14O2
|
142.099380
|
|
LMFA07010957
|
Methyl 5-methylhexanoate
|
methyl 5-methylhexanoate
|
SFE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA07010957
|
Methyl 5-methylhexanoate
|
methyl 5-methylhexanoate
|
SFE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050353
|
N-methylanthraniloyl-CoA
|
N-methylanthraniloyl-CoA
|
|
C29H43N8O17P3S
|
900.167973
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA07050342
|
L-erythro-3-methylmalyl-CoA
|
2S-methyl-3R-hydroxy-4-carboxybutanoyl-CoA
|
CoA 5:1;O3
|
C26H42N7O20P3S
|
897.141819
|
|
LMFA08020247
|
N-margaroyl taurine
|
N-heptadecanoyl taurine
|
NAT 17:0
|
C19H39NO4S
|
377.259980
|
|
LMFA04020241
|
(4R,8R,11R)-d5-7-NeuroF[7S,10S]
|
(R,E)-4-hydroxy-6-((2S,3R,5S)-3-hydroxy-5-((R,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04030001
|
Resolvin D2
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04030001
|
Resolvin D2
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04030001
|
Resolvin D2
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA01140031
|
Alepramic acid
|
3-(2-cyclopenten-1-yl)-propanoic acid
|
FA 8:2
|
C8H12O2
|
140.083730
|
|
LMFA01140031
|
Alepramic acid
|
3-(2-cyclopenten-1-yl)-propanoic acid
|
FA 8:2
|
C8H12O2
|
140.083730
|
|
LMFA04010006
|
11-F4-NeuroP
|
3-(3,5-dihydroxy-2-((1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04020283
|
(14R,17S,20R)-d18-13-NeuroF[13R,16S]
|
(4Z,7Z,10Z)-12-((2R,3R,5S)-5-((1S,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA02000315
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235146
|
|
LMFA02000315
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235146
|
|
LMFA02000315
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
15-Hydroxy-9Z,15Z-octadecadienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235146
|
|
LMFA02000302
|
12,13-Dihydroxyoleic acid
|
12S,13S-dihydroxy-9Z-Octadecenoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA02000302
|
12,13-Dihydroxyoleic acid
|
12S,13S-dihydroxy-9Z-Octadecenoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA02000302
|
12,13-Dihydroxyoleic acid
|
12S,13S-dihydroxy-9Z-Octadecenoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA01050040
|
2-hydroxy-tridecanoic acid
|
2-hydroxy-tridecanoic acid
|
FA 13:0;O
|
C13H26O3
|
230.188195
|
|
LMFA02000324
|
3Z,9Z-Octadecadienoic acid
|
3Z,9Z-Octadecadienoic acid
|
FA 18:2
|
C18H32O2
|
280.240231
|
|
LMFA02000324
|
3Z,9Z-Octadecadienoic acid
|
3Z,9Z-Octadecadienoic acid
|
FA 18:2
|
C18H32O2
|
280.240231
|
|
LMFA04020061
|
(13R,16S,20S)-d18-14-NeuroF[14R,17R]
|
(R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4S,5R)-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01140043
|
5,6-methylenetetradecanoic acid
|
5,6-methylenetetradecanoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
|
LMFA01140043
|
5,6-methylenetetradecanoic acid
|
5,6-methylenetetradecanoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
|
LMFA01031050
|
4Z,7Z-Hexadecadienoic acid
|
4Z,7Z-Hexadecadienoic acid
|
FA 16:2
|
C16H28O2
|
252.208930
|
|
LMFA01031091
|
5E,11Z-Eicosadienoic acid
|
5E,11Z-Eicosadienoic acid
|
FA 20:2
|
C20H36O2
|
308.271531
|
|
LMFA01031130
|
Antibiotic LA-1
|
9-oxo-2Z,4,5,7Z-decatetraenoic acid
|
FA 10:5;O
|
C10H10O3
|
178.062995
|
|
LMFA01031130
|
Antibiotic LA-1
|
9-oxo-2Z,4,5,7Z-decatetraenoic acid
|
FA 10:5;O
|
C10H10O3
|
178.062995
|
|
LMFA07030023
|
Type III cyanolipid 22:0 ester
|
(3-cyano-2-methylprop-2E-en-1-yl) docosanoate
|
|
C27H49NO2
|
419.376330
|
|
LMFA07030023
|
Type III cyanolipid 22:0 ester
|
(3-cyano-2-methylprop-2E-en-1-yl) docosanoate
|
|
C27H49NO2
|
419.376330
|
|
LMFA07030023
|
Type III cyanolipid 22:0 ester
|
(3-cyano-2-methylprop-2E-en-1-yl) docosanoate
|
|
C27H49NO2
|
419.376330
|
|
LMFA03130048
|
(9R,12R,15S)-d13-8-IsoF[8R,11R]
|
(Z)-7-((2R,3R,5R)-5-((1R,4S,E)-1,4-dihydroxynon-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03130091
|
(8S,11R,14R)-d9-12-IsoF[12S,15R]
|
(5Z,8S,9Z,11R)-8,11-dihydroxy-11-((2S,4R,5R)-4-hydroxy-5-pentyltetrahydrofuran-2-yl)undeca-5,9-dienoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03130204
|
(8R,12R,15R)-d9-11-IsoF[11R,14R]
|
(R,5Z,9E)-8-hydroxy-10-((2R,3R,5R)-3-hydroxy-5-((R)-1-hydroxyhexyl)tetrahydrofuran-2-yl)deca-5,9-dienoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04020314
|
(13R,16S,19R)-d14-17-NeuroF[17a,20b]
|
(4Z,7Z,10Z,13R,14E,16S)-16-((2R,4R,5S)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-13,16-dihydroxyhexadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA02040093
|
(10S,13S,16R)-d14-9-PhytoF[9S,12S]
|
8-((2S,3S,5S)-5-((1S,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA04020516
|
(4S,7R,10R)-d5-8-NeuroF[8S,11S]
|
(4S,7R,E)-4,7-dihydroxy-7-((2S,4R,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020506
|
(4R,7S,10R)-d5-8-NeuroF[8R,11S]
|
(4R,7S,E)-4,7-dihydroxy-7-((2R,4R,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|